Clinical Trials Directory

Trials / Completed

CompletedNCT05271734

Evaluation of the Compatibility of Different Eye Lid Retractors to the Direct Selective Laser Trabeculoplasty (DSLT) Procedure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
BelkinVision · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Direct Selective Laser Trabeculoplasty (DSLT) is an emerging therapeutic technology to treat glaucoma. DSLT was previously tested in 2 clinical trials and demonstrated promising safety and efficacy results in reducing the patient's intra ocular pressure. Experience gained in the previous clinical studies indicates that a full exposure of the limbal area may be a challenge in patients with narrow palpebral fissures, narrow or floppy eyelids, and patients with deep-set eyes.

Detailed description

The DSLT procedure is carried out in the doctor's office while the patient sits in front of the DSLT device (termed the "Eagle" device) for couple of minutes. In this procedure, 120 laser applications are performed around the full circumference of the ocular limbus, after the system automatically recognizes the limbal target area. It is therefore essential that a full exposure of 3600 limbal area will be achieved, and this is done by placing an eye lid retractor (speculum) in the treated eye at the beginning of the procedure. The purpose of this study is to evaluate the compatibility of different types of lid retractors. The lid retractors will be tested in adult volunteers visiting the study eye clinic for any reason.

Conditions

Interventions

TypeNameDescription
DEVICELid retractor placementInsertion of a lid retractor to find out if the corneal limbus is exposed in 360 degress

Timeline

Start date
2021-06-06
Primary completion
2022-06-15
Completion
2022-08-15
First posted
2022-03-09
Last updated
2023-01-23

Locations

1 site across 1 country: Georgia

Source: ClinicalTrials.gov record NCT05271734. Inclusion in this directory is not an endorsement.